Home/Investors/Takeda Ventures

Takeda Ventures

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

5

Top Stage

Phase 1

Investment Focus

Rare Diseases Hematology Metabolic Disorders Cardiovascular Neurology

Portfolio Companies

Company	Stage	Valuation	Focus
Be Biopharma	Phase 1	—	Rare Diseases, Hematology
VitaCell Biologics	preclinical	—	Cardiovascular, Neurology

Frequent Co-Investors

Atlas Venture1 shared Versant Ventures1 shared ARCH Venture Partners1 shared Sofinnova Partners1 shared Bristol Myers Squibb1 shared Nextech Invest1 shared RA Capital Management1 shared Longwood Fund1 shared